Discovery of novel theophylline derivatives bearing tetrazole scaffold for the treatment of Alzheimer's disease
- PMID: 40041377
- PMCID: PMC11877286
- DOI: 10.1039/d5ra00488h
Discovery of novel theophylline derivatives bearing tetrazole scaffold for the treatment of Alzheimer's disease
Abstract
Alzheimer's disease (AD) is associated with AChE and BACE1 enzymes. Designing inhibitors for preventing these enzymes can be benefit for AD treatment. In this context, theophylline derivatives were generated to prevent the biological activity of AChE and BACE1. In particular, the potential inhibitory of these compounds was rapidly and accurately estimated via knowledge-methods. The in vitro tests were then performed to validate the artificial intelligent approach. Among these, compound 12 exhibited the most potent AChE inhibition with an IC50 of 15.68 μM, while showing limited activity against BACE1. In addition, six compounds were indicated that are able to inhibit AChE, however, the theophylline derivatives play poor performance over the BACE1 target. Atomistic simulations were finally applied to clarify the ligand-binding mechanism to the biological target. The outcomes disclose that theophylline derivatives rigidly form van der Waals interactions to AChE via π-stacking and SC contacts. Overall, the theophylline derivatives may offer a potential scaffold for novel anti-AD agents.
This journal is © The Royal Society of Chemistry.
Conflict of interest statement
There are no conflicts to declare.
Figures




Similar articles
-
Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.Eur J Med Chem. 2021 Apr 5;215:113224. doi: 10.1016/j.ejmech.2021.113224. Epub 2021 Feb 2. Eur J Med Chem. 2021. PMID: 33582578
-
6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.Int J Risk Saf Med. 2015;27 Suppl 1:S69-71. doi: 10.3233/JRS-150694. Int J Risk Saf Med. 2015. PMID: 26639718
-
Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer's disease.Bioorg Chem. 2017 Oct;74:126-133. doi: 10.1016/j.bioorg.2017.07.014. Epub 2017 Jul 25. Bioorg Chem. 2017. PMID: 28780149
-
Exploring the Benzazoles Derivatives as Pharmacophores for AChE, BACE1, and as Anti-Aβ Aggregation to Find Multitarget Compounds against Alzheimer's Disease.Molecules. 2024 Oct 9;29(19):4780. doi: 10.3390/molecules29194780. Molecules. 2024. PMID: 39407708 Free PMC article. Review.
-
Anti-Alzheimer's disease potential of traditional chinese medicinal herbs as inhibitors of BACE1 and AChE enzymes.Biomed Pharmacother. 2022 Oct;154:113576. doi: 10.1016/j.biopha.2022.113576. Epub 2022 Aug 22. Biomed Pharmacother. 2022. PMID: 36007279 Review.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous